CUSIP 483497103COMKALVQ4 2025
76 filings · latest Jan 13, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vr Adviser, LLC | 6.73M | $108.67M |
| 2 | Frazier Life Sciences Management, L.P. | 5.04M | $81.39M |
| 3 | Suvretta Capital Management, LLC | 4.77M | $77.01M |
| 4 | Tang Capital Management LLC | 4.57M | $73.86M |
| 5 | Blackrock, Inc. | 3.75M | $60.63M |
| 6 | Millennium Management LLC | 2.90M | $46.78M |
| 7 | Capital World Investors | 2.81M | $45.36M |
| 8 | Vanguard Group Inc | 2.51M | $40.52M |
| 9 |
| 4 | Nov 14, 2025 | Vestal Point Capital, LP | 13G/A | 1.5% | 750.0K | SEC |
| 5 | Nov 10, 2025 | Millennium Management LLC | 13G | 11.0% | 2.53M | SEC |
| 6 | Nov 4, 2025 | Frazier Life Sciences Public Fund, L.P. | 13D/A | 6.9% | — | SEC |
| 7 | Aug 20, 2025 | Frazier Life Sciences Public Fund, L.P. | 13D/A | 4.8% | — | SEC |
| 8 | May 15, 2025 | Tang Capital Management, LLC | 13G/A | 9.9% | 4.94M | SEC |
| 9 | May 13, 2025 | Capital World Investors | 13G/A | 6.4% | 3.18M | SEC |
| 10 | Nov 14, 2024 | Tang Capital Management LLC | 13G/A | 10.0% | 4.32M | SEC |
See the full Schedule 13D/13G history for Kalvista Pharmaceuticals Inc.
Unlock full history| Silverarc Capital Management, LLC |
| 2.43M |
| $39.20M |
| 10 | Point72 Asset Management, L.P. | 2.28M | $36.88M |